Oriola-KD Corp. Series B | |
Stock Exchange | Nasdaq Helsinki |
EPS |
EUR0.06 |
Market Cap |
EUR355.51 M |
Shares Outstanding |
126.05 M |
Public Float |
93.04 M |
Oriola-KD Corp. Series A | |
Stock Exchange | Nasdaq Helsinki |
EPS |
EUR0.06 |
Market Cap |
EUR357.32 M |
Shares Outstanding |
55.43 M |
Public Float |
29.93 M |
Address |
Orionintie 5 Espoo UU 02101 Finland |
Employees | - |
Website | http://www.oriola-kd.com |
Updated | 07/08/2019 |
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. The company provides a wide service offering covering pharmaceutical distribution, branded products, and other tailored services. It operates through the following segments: Consumer, Services, and Healthcare. |